Drugmakers in Medicare Price Negotiations Spent Less on Research Than on Shareholder Payments, Marketing and Overhead: Report [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
buybacks, dividends, marketing and administrative costs than they did on research and development, according to a report from Accountable.US, a left-leaning watchdog group. The report says that the eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Merck, Novartis and Novo Nordisk — spent $95.9 billion on research and development expenses, compared to $162 billion on stock buybacks, dividends, and marketing and administrative costs and almost $500 million on compensation for their boards and executives. “Additionally, these companies spent at least $83.2 million on trade association dues, $10.6 million on political contributions and $57.8 million on lobbying, all in 2023 alone,” Accountable.US adds. “Meanwhile, these companies pulled in a combined $367 billion in sales in 2023, according to their financial filings.” The group says that four of the companies — Johnson & Johnson, Bristol Myers Squibb, Novartis and Novo Nordisk — spent more on
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Waters And Johns Solidify Stakes As Pickleball Number Ones At PPA Atlanta Slam [Forbes]Forbes
- United States Platelet Rich Plasma Industry Research 2024-2032: Increasing Healthcare Expenditures Fuel Growth of PRP-Based Procedures, Non-Invasive Medical Procedures Drive PRP Therapy Demand [Yahoo! Finance]Yahoo! Finance
- Ethereum price today: ETH is down 1.01% today [USA TODAY]USA TODAY
- Global Surgical Equipment Market is Anticipated to Hit USD 32.96 Billion, With a CAGR of 8.8% CAGR by 2032 - Report by Polaris Market Research (PMR) [Yahoo! Finance]Yahoo! Finance
- TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major secondary endpoints, including highly statistically significant rates of endoscopic remission [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/20/24 - Form 25-NSE
- 5/17/24 - Form 8-K
- 5/16/24 - Form 424B2
- JNJ's page on the SEC website